Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Kay

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cytometry. Part B, Clinical Cytometry|September 13, 2007
Calibration standards for antigen quantification in CLLNeil Kay
Leukemia & Lymphoma|August 23, 2006
T-cell abnormalities in patients with chronic lymphocytic leukemiaTait Shanafelt, Neil Kay
Leukemia & Lymphoma|January 19, 2008
Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemiaPaul Thurmes, Timothy Call, Susan Slager, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 24, 2013
Recurrent chromosome abnormalities define nonoverlapping unique subgroups of tumors in patients with chronic lymphocytic leukemia and known karyotypic abnormalitiesVictor H Jimenez-Zepeda, Wee Joo Chng, Roelandt F J Schop, et al.
British Journal of Haematology|July 27, 2005
Diagnostic criteria for monoclonal B-cell lymphocytosisGerald E Marti, Andy C Rawstron, Paolo Ghia, et al.
Leukemia & Lymphoma|November 9, 2010
Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemiaTait Shanafelt, Clive Zent, John Byrd, et al.
Blood|June 29, 2006
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myelomaWee J Chng, Roelandt F Schop, Tammy Price-Troska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2021
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III TrialJohn C Byrd, Peter Hillmen, Paolo Ghia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2021
Recognizing Unmet Need in the Era of Targeted Therapy for CLL/SLL: "What's Past Is Prologue" (Shakespeare)Anthony R Mato, Matthew S Davids, Jeff Sharman, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cytometry. Part B, Clinical Cytometry|September 13, 2007
Calibration standards for antigen quantification in CLLNeil Kay
Leukemia & Lymphoma|August 23, 2006
T-cell abnormalities in patients with chronic lymphocytic leukemiaTait Shanafelt, Neil Kay
Leukemia & Lymphoma|January 19, 2008
Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemiaPaul Thurmes, Timothy Call, Susan Slager, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 24, 2013
Recurrent chromosome abnormalities define nonoverlapping unique subgroups of tumors in patients with chronic lymphocytic leukemia and known karyotypic abnormalitiesVictor H Jimenez-Zepeda, Wee Joo Chng, Roelandt F J Schop, et al.
British Journal of Haematology|July 27, 2005
Diagnostic criteria for monoclonal B-cell lymphocytosisGerald E Marti, Andy C Rawstron, Paolo Ghia, et al.
Leukemia & Lymphoma|November 9, 2010
Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemiaTait Shanafelt, Clive Zent, John Byrd, et al.
Blood|June 29, 2006
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myelomaWee J Chng, Roelandt F Schop, Tammy Price-Troska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2021
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III TrialJohn C Byrd, Peter Hillmen, Paolo Ghia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2021
Recognizing Unmet Need in the Era of Targeted Therapy for CLL/SLL: "What's Past Is Prologue" (Shakespeare)Anthony R Mato, Matthew S Davids, Jeff Sharman, et al.
Pageof 1